Dixon Hughes Goodman Wealth Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	$0	Sell	5 -19	-79%	–	﹤0.01%	1010
2021 Q4	$2K	Buy	+24	New	+$2K	﹤0.01%	684